HIV/AIDS epidemic in the United States

HIV/AIDS epidemic in the United States
Name	Human immunodeficiency virus (HIV)
First outbreak	1980s United States
Virus family	Retroviridae

Contents

HIV/AIDS epidemic in the United States

The HIV/AIDS epidemic in the United States is a major public health crisis that emerged in the early 1980s and has since affected millions across diverse populations. Early clinical identification involved multiple hospitals and research centers including the Centers for Disease Control and Prevention, Johns Hopkins Hospital, University of California, San Francisco, Fenway Health, and Mount Sinai Hospital, while advocacy and policy responses engaged actors such as Act Up, Gay Men's Health Crisis, Human Rights Campaign, National Institutes of Health, and state health departments.

History

Initial reports in 1981 linked unusual opportunistic infections and rare cancers observed at institutions like Los Angeles County+USC Medical Center, New York University Hospital, University of Washington, and Cook County Hospital to a new syndrome. Early epidemiologic work by the Centers for Disease Control and Prevention and researchers at Rockefeller University, Harvard Medical School, Columbia University Irving Medical Center, and University of California, Los Angeles established clinical definitions and surveillance systems. Identification of Human immunodeficiency virus as the etiologic agent involved laboratories at Pasteur Institute, National Institutes of Health, Scripps Research Institute, and collaborations with clinicians from Brigham and Women's Hospital. Public activism by Act Up, Terrence McNally, Larry Kramer, and organizations such as Gay Men's Health Crisis and Elizabeth Taylor's American Foundation for AIDS Research pressured policymakers including members of United States Congress, administrations of Ronald Reagan, George H. W. Bush, and Bill Clinton to increase funding for research, treatment access, and anti-discrimination measures. Breakthroughs included implementation of combination antiretroviral therapy following trials at University of California, San Francisco, Massachusetts General Hospital, Fred Hutchinson Cancer Research Center, and multinational collaborations involving World Health Organization and Joint United Nations Programme on HIV/AIDS.

Surveillance by the Centers for Disease Control and Prevention and studies by National Institutes of Health show heterogeneous incidence and prevalence across states such as New York (state), California, Florida, Texas, and regions like the Southeastern United States. Risk group data collected by institutions including Emory University, Johns Hopkins Bloomberg School of Public Health, Rutgers University, and University of Michigan highlight disparities among populations connected to intersections with African American history, Latino Americans, Native American tribes, Puerto Rico, and urban areas like New York City, Los Angeles, Miami, and Atlanta. Demographic analyses by Kaiser Family Foundation, Pew Research Center, RAND Corporation, and Urban Institute document age-specific trends, gender distribution involving cisgender men, transgender women, and women of color, and socioeconomic gradients studied at Columbia University Mailman School of Public Health and Yale School of Public Health.

Epidemiologic research at Centers for Disease Control and Prevention, Johns Hopkins University, University of California, San Francisco, Brown University, and University of North Carolina at Chapel Hill has established primary transmission routes: sexual contact among men who have sex with men (studied in cohorts at Fenway Health and Gay Men's Health Crisis), heterosexual transmission affecting partners in Puerto Rico and Hispanic and Latino American communities, injection drug use documented in outbreaks in places like Scott County, Indiana and Syracuse, New York, and iatrogenic transmission concerns addressed by Food and Drug Administration and blood safety programs developed with American Red Cross and Centers for Disease Control and Prevention. Co-infections with Hepatitis C virus and Mycobacterium tuberculosis exacerbate morbidity, while social determinants evaluated by Urban Institute, Robert Wood Johnson Foundation, and Brookings Institution influence vulnerability.

Prevention strategies promoted by Centers for Disease Control and Prevention, World Health Organization, and community clinics like Fenway Health include condom distribution, syringe services programs studied in trials at Johns Hopkins Bloomberg School of Public Health, pre-exposure prophylaxis (PrEP) with drugs developed by pharmaceutical companies and tested in trials affiliated with University of California, San Francisco, Harvard Medical School, and Fred Hutchinson Cancer Research Center, and behavioral interventions piloted by Kaiser Permanente and Planned Parenthood. Diagnostic testing evolved from enzyme immunoassays validated by Food and Drug Administration to rapid tests deployed by American Red Cross and point-of-care programs at Community Health Centers. Antiretroviral therapy regimens recommended by Department of Health and Human Services and informed by clinical trials at National Institutes of Health and University of Pennsylvania transformed prognosis; treatment-as-prevention frameworks were advanced through collaborations with Joint United Nations Programme on HIV/AIDS and World Health Organization.

Federal policy instruments including funding allocations by Ryan White Comprehensive AIDS Resources Emergency Act programs administered through Health Resources and Services Administration, regulatory actions by Food and Drug Administration, and research grants from National Institutes of Health have shaped the response. State-level initiatives in California, New York (state), Georgia (U.S. state), and Florida (state) implemented prevention and care programs via departments modeled on guidance from Centers for Disease Control and Prevention and advocacy from organizations like Human Rights Campaign and NAACP. Litigation and legal protections were pursued through courts including the United States Supreme Court and civil rights organizations such as Lambda Legal and American Civil Liberties Union, influencing policies on confidentiality, criminalization statutes reviewed in state legislatures, and workplace protections under Americans with Disabilities Act of 1990.

The epidemic catalyzed activism involving cultural figures such as Elizabeth Taylor, playwrights like Tony Kushner, and grassroots groups including Act Up and Black AIDS Institute, while shaping discourse in media outlets like The New York Times, The Washington Post, and Rolling Stone. Stigma and discrimination affected people living with HIV in employment disputes heard in courts, housing cases brought before local tribunals, and civil rights campaigns organized by NAACP, Human Rights Campaign, and faith-based groups such as Metropolitan Community Church and Ebenezer Baptist Church. Intersectional analyses by scholars at Columbia University, Harvard University, Princeton University, and University of California, Berkeley connected stigma to race, sexuality, and poverty, informing community-based interventions implemented by Fenway Health, Gay Men's Health Crisis, Black AIDS Institute, and local health departments.

Category:Health in the United States Category:HIV/AIDS